Income statement and cash flow are moderate; balance sheet is weak.
Next earnings: 2026-10-29 (BMO), EPS Forecast: $1.28
Rated Sell for the last 12 quarters. This quarter: +2.1.
Change vs previous quarter.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.